blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3294332

EP3294332 - RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.02.2023
Database last updated on 20.05.2024
FormerGrant of patent is intended
Status updated on  15.05.2022
FormerExamination is in progress
Status updated on  21.04.2020
FormerRequest for examination was made
Status updated on  16.02.2018
FormerThe international publication has been made
Status updated on  18.11.2016
Most recent event   Tooltip03.02.2023Application deemed to be withdrawnpublished on 08.03.2023  [2023/10]
Applicant(s)For all designated states
Joslin Diabetes Center, Inc.
One Joslin Place
Boston, MA 02215 / US
[2018/12]
Inventor(s)01 / KING, George Liang
101 Centre Street
Dover, Massachusetts 02030 / US
02 / KEENAN, Hillary A.
118 Oak Street
Welleley, Massachusetts 02482 / US
 [2018/12]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[N/P]
Former [2018/12]Donald, Jenny Susan
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date16793708.516.05.2016
[2018/12]
WO2016US32752
Priority number, dateUS201562161566P14.05.2015         Original published format: US 201562161566 P
US201562162439P15.05.2015         Original published format: US 201562162439 P
[2018/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016183585
Date:17.11.2016
Language:EN
[2016/46]
Type: A1 Application with search report 
No.:EP3294332
Date:21.03.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2016 takes the place of the publication of the European patent application.
[2018/12]
Search report(s)International search report - published on:US17.11.2016
(Supplementary) European search report - dispatched on:EP26.11.2018
ClassificationIPC:A61K39/385, A61P9/10, A61P27/02, A61P27/06
[2018/12]
CPC:
A61K31/711 (EP,US); A61K31/7088 (EP,US); A61K35/76 (EP,US);
A61K38/16 (EP,US); A61K38/1709 (EP,US); A61K45/06 (EP,US);
A61K48/005 (EP,US); A61P27/02 (EP); A61P27/06 (EP);
A61P9/10 (EP); C12N15/86 (EP,US); C12N15/861 (US);
A61K9/0048 (EP,US); A61P27/00 (EP,US); C12N2740/16043 (EP,US);
C12N2740/16071 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/12]
TitleGerman:RETINOLBINDENDES PROTEIN 3 (RBP3) ALS SCHUTZFAKTOR BEI NICHT DIABETISCHER NETZHAUTDEGENERATION[2018/12]
English:RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION[2018/12]
French:PROTÉINE 3 DE LIAISON AU RÉTINOL (RBP3) À UTILISER EN TANT QUE FACTEUR DE PROTECTION DANS LA DÉGÉNÉRESCENCE RÉTINIENNE NON DIABÉTIQUE[2018/12]
Entry into regional phase11.12.2017National basic fee paid 
11.12.2017Search fee paid 
11.12.2017Designation fee(s) paid 
11.12.2017Examination fee paid 
Examination procedure11.12.2017Examination requested  [2018/12]
11.12.2017Date on which the examining division has become responsible
24.06.2019Amendment by applicant (claims and/or description)
24.04.2020Despatch of a communication from the examining division (Time limit: M06)
21.10.2020Reply to a communication from the examining division
25.02.2021Despatch of a communication from the examining division (Time limit: M06)
27.07.2021Reply to a communication from the examining division
16.05.2022Communication of intention to grant the patent
27.09.2022Application deemed to be withdrawn, date of legal effect  [2023/10]
18.10.2022Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2023/10]
Fees paidRenewal fee
29.05.2018Renewal fee patent year 03
28.05.2019Renewal fee patent year 04
27.05.2020Renewal fee patent year 05
27.05.2021Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.05.202207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO03079968  (YEDA RES & DEV [IL], et al) [A] 1-12* examples 1,2; claims 1,5 *;
 [XDI]US2014187498  (KING GEORGE L [US], et al) [XD] 1,2,6-12 * figures 11-16; examples 7-9; claims 33-36 * [I] 1-12;
 [E]EP3323411  (SEOUL NAT UNIV R&DB FOUNDATION [KR], et al) [E] 1-12 * claims 5-7 *;
 [A]  - JEFFREY WISARD ET AL, "Exaggerated Eye Growth in IRBP-Deficient Mice in Early Development", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20110729), vol. 52, no. 8, doi:10.1167/iovs.10-7129, ISSN 1552-5783, page 5804, XP055519660 [A] 1-12 * page 5804 *

DOI:   http://dx.doi.org/10.1167/iovs.10-7129
 [A]  - GREGORY I. LIOU ET AL, "Early Onset Photoreceptor Abnormalities Induced by Targeted Disruption of the Interphotoreceptor Retinoid-Binding Protein Gene", THE JOURNAL OF NEUROSCIENCE, US, (19980615), vol. 18, no. 12, doi:10.1523/JNEUROSCI.18-12-04511.1998, ISSN 0270-6474, pages 4511 - 4520, XP055519664 [A] 1-12 * figure 6 *

DOI:   http://dx.doi.org/10.1523/JNEUROSCI.18-12-04511.1998
 [A]  - Grazyna Adamus ET AL, "Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats", Molecular vision, United States, (20120101), pages 2323 - 2337, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441155/pdf/mv-v18-2323.pdf, (20181029), XP055519740 [A] 1-12 * page 2324 *
 [A]  - PEDRO HENRIQUE PAPOTTO ET AL, "Immunotherapeutic strategies in autoimmune uveitis", AUTOIMMUNITY REVIEWS, NL, (20140901), vol. 13, no. 9, doi:10.1016/j.autrev.2014.05.003, ISSN 1568-9972, pages 909 - 916, XP055519782 [A] 1-12 * page 910 *

DOI:   http://dx.doi.org/10.1016/j.autrev.2014.05.003
 [A]  - JUN CHEN ET AL, "Use of Optical Coherence Tomography and Electroretinography to Evaluate Retinal Pathology in a Mouse Model of Autoimmune Uveitis", PLOS ONE, (20130514), vol. 8, no. 5, doi:10.1371/journal.pone.0063904, page e63904, XP055519788 [A] 1-12 * page 1 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0063904
 [A]  - PEREZ VICTOR L ET AL, "Immune mechanisms in inflammatory and degenerative eye disease", TRENDS IN IMMUNOLOGY, ELSEVIER LTD. * TRENDS JOURNALS, GB, (20150513), vol. 36, no. 6, doi:10.1016/J.IT.2015.04.003, ISSN 1471-4906, pages 354 - 363, XP029611602 [A] 1-12 * page 361 *

DOI:   http://dx.doi.org/10.1016/j.it.2015.04.003
 [A]  - RITA VÁMOS ET AL, "The Structure and Function of the Macula in Patients with Advanced Retinitis Pigmentosa", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20111027), vol. 52, no. 11, doi:10.1167/iovs.11-7780, ISSN 1552-5783, page 8425, XP055519971 [A] 1-12 * page 8425 *

DOI:   http://dx.doi.org/10.1167/iovs.11-7780
 [A]  - SONGHUA LI ET AL, "Secretory Defect and Cytotoxicity : THE POTENTIAL DISEASE MECHANISMS FOR THE RETINITIS PIGMENTOSA (RP)-ASSOCIATED INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN (IRBP)", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20130419), vol. 288, no. 16, doi:10.1074/jbc.M112.418251, ISSN 0021-9258, pages 11395 - 11406, XP055519992 [A] 1-12 * page 11396 *

DOI:   http://dx.doi.org/10.1074/jbc.M112.418251
 [A]  - GAVIN ARNO ET AL, "Lack of Interphotoreceptor Retinoid Binding Protein Caused by Homozygous Mutation of RBP3 Is Associated With High Myopia and Retinal Dystrophy", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20150410), vol. 56, no. 4, doi:10.1167/iovs.15-16520, ISSN 1552-5783, page 2358, XP055519998 [A] 1-12 * page 2358 *

DOI:   http://dx.doi.org/10.1167/iovs.15-16520
 [A]  - "Abstract Book 2008", DIABETOLOGIA ; CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM, SPRINGER, BERLIN, DE, (20080813), vol. 51, no. 1, doi:10.1007/S00125-008-1117-6, ISSN 1432-0428, pages 1 - 588, XP019776270 [A] 1-12 * page S470, paragraph 1158 *

DOI:   http://dx.doi.org/10.1007/s00125-008-1117-6
International search[X]US2012276127  (ADAMUS GRAZYNA [US], et al) [X] 1-2, 3/1-2 * ; abstract; paragraphs [0007], [0010]. [0186], [0200], [0219] *;
 [A]US2014364338  (SCHAFFER DAVID V [US], et al) [A] 1-2, 3/1-2 * ; entire document *;
 [A]US2011008382  (BURROWS GREGORY G [US], et al) [A] 1-2, 3/1-2 * ; entire document *
by applicantUS2014187498
 US2011046004
 US5118937
 US5045694
 US5719060
 US6225047
 US2005048542
 US4868116
 US4980286
 WO8907136
 WO8902468
 WO8905345
 WO9207573
 WO9106309
 JP1047381
 EP0043075
 US5328470
 US4522811
 US2009136445
    - HUMAYAN et al., Invest Ophthalmol Vis Sci, (19990000), vol. 40, pages 143 - 148
    - "GenBank", Database accession no. NP_002891.1
    - LIOU et al., Somat. Cell Molec. Genet., (19870000), vol. 13, pages 315 - 323
    - NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, pages 444 - 453
    - HOLLANDER et al., Invest. Ophthal. Vis. Sci., (20090000), vol. 50, pages 1864 - 1872
    - KSANTINI et al., Ophthal. Genet., (20100000), vol. 31, pages 200 - 204
    - LI et al., J. Biol. Chem., (20130000), vol. 288, pages 11395 - 11406
    - LIOU et al., J. Neurosci., (19980000), vol. 18, pages 4511 - 4520
    - CHAN et al., Arch Ophthalmol, (20060200), vol. 124, no. 2, pages 193 - 198
    - ALAMOUTIFUNK, Br J Ophthalmol, (20030700), vol. 87, no. 7, pages 899 - 901
    - KIM, Am J Clin Pathol, (20100000), vol. 134, pages 157 - 162
    - YASUN, Anal Chem, (20120000), vol. 84, no. 14, pages 6008 - 6015
    - BRODY, Expert Rev Mol Diagn, (20100000), vol. 10, no. 8, pages 1013 - 1022
    - PHILIPS, PLOS One, (20140000), vol. 9, no. 11, page e110641
    - PFAFFE, Clin Chem, (20110000), vol. 57, no. 5, pages 675 - 687
    - WILSON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 3014 - 3018
    - CUNHA-VAZ, "Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes", Diabetes, (19830000), vol. 2, pages 20 - 7
    - KONTERMANNDUBEL, Antibody Engineering, Springer, (20100521), vol. 1
    - JOSEPHSON et al., Bioconjug. Chem., (19990000), vol. 10, no. 2, pages 186 - 91
    - DIEHL, "Beads, Emulsion, Amplification, Magnetics", Nat Methods, (20060000), vol. 3, pages 551 - 559
    - MEULI et al., J. Invest. Dermatol., (20010000), vol. 116, no. 1, pages 131 - 135
    - BERNARD, Clin Chem, (20020000), vol. 48, no. 8, pages 1178 - 1185
    - MIRANDA, Kidney International, (20100000), vol. 78, pages 191 - 199
    - BIANCHI, EMBO Mol Med, (20110000), vol. 3, pages 495 - 503
    - TAYLOR, Front. Genet., (20130000), vol. 4, page 142
    - NORDSTROM, Biotechnol. Appl. Biochem., (20000000), vol. 31, no. 2, pages 107 - 112
    - AHMADIAN, Anal Biochem, (20000000), vol. 280, pages 103 - 110
    - EKINSCHU, Trends in Biotechnology, (19990000), vol. 17, pages 217 - 218
    - MACBEATHSCHREIBER, Science, (20000000), vol. 289, no. 5485, pages 1760 - 1763
    - MOHR et al., Diabetes, (20020000), vol. 51, pages 1172 - 9
    - KOSTIC et al., Gene Therapy, (20030000), vol. 10, pages 818 - 821
    - MILLER, Blood, (19900000), vol. 76, page 271
    - MCLAUGHLIN et al., J. Virol., (19890000), vol. 62, pages 1963 - 1973
    - EGLITIS et al., Science, (19850000), vol. 230, pages 1395 - 1398
    - ARMENTANO et al., Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 6141 - 6145
    - FERRY et al., Proc. Natl. Acad. Sci. USA, (19910000), vol. 88, pages 8377 - 8381
    - ROSENFELD et al., Science, (19910000), vol. 252, pages 1802 - 1805
    - VAN BEUSECHEM et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 10892 - 10895
    - KAY et al., Human Gene Therapy, (19920000), vol. 3, pages 641 - 647
    - HWU et al., J. Immunol., (19930000), vol. 150, pages 4104 - 4115
    - BERKNER et al., BioTechniques, (19880000), vol. 6, page 616
    - ROSENFELD et al., Cell, (19920000), vol. 68, pages 143 - 155
    - HAJ-AHMANDGRAHAM, J. Virol., (19860000), vol. 57, page 267
    - MUZYCZKA et al., Curr. Topics in Micro and Immunol, (19920000), vol. 158, pages 97 - 129
    - FLOTTE et al., Am. J. Respir. Cell. Mol. Biol., (19920000), vol. 7, pages 349 - 356
    - TRATSCHIN et al., Mol. Cell. Biol., (19850000), vol. 4, pages 2072 - 2081
    - HERMONAT et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6466 - 6470
    - WONDISFORD et al., Mol. Endocrinol., (19880000), vol. 2, pages 32 - 39
    - TRATSCHIN et al., J. Virol., (19840000), vol. 51, pages 611 - 619
    - FLOTTE et al., J. Biol. Chem., (19930000), vol. 268, pages 3781 - 3790
    - COHEN et al., Gene Ther, (20000000), vol. 7, no. 21, pages 1867 - 905
    - MIZUNO et al., No Shinkei Geka, (19920000), vol. 20, pages 547 - 551
    - DYKA et al., Adv Exp Med Biol., (20140000), vol. 801, pages 695 - 701
    - BAINBRIDGE et al., N Engl J Med, (20080000), vol. 358, pages 2231 - 2239
    - CHEN et al., PNAS USA, (19940000), vol. 91, pages 3054 - 3057
    - LOSA et al., Pharmaceutical Research, (19930000), vol. 10, no. 1, pages 80 - 87
    - GASCO et al., J. Pharma Biomed Anal., (19890000), vol. 7, no. 4, pages 433 - 439
    - FISCHER et al., Eur J Ophthalmol, (20110000), vol. 6, pages 20 - 6
    - TANGRIKHURANA, Intl J Res Pharma Biomed Sci., (20110000), vol. 2, no. 4, pages 1541 - 1442
    - SALVADOR-SILVA et al., "Retinoid processing proteins in the ocular ciliary epithelium", Molecular vision, (20050000), vol. 11, pages 356 - 65
    - GUPTA et al., J Pharm Bioallied Sci, (20150100), vol. 7, no. 1, pages 9 - 14
    - SAETTONESALMINEN, Adv Drug Deliv Rev, (19950000), vol. 16, pages 95 - 106
    - "Mucoadhesive polymers in ophthalmic drug delivery", JOHNSTON TPDIAS CSMITRA AK, Ophthalmic Drug Delivery Systems, Marcel Dekker, (20030000), vol. 130
    - "Ocular Pharmacokinetics", CHUN DKSHAPIRO AABELSON MB, Principles and Practice of Ophthalmology, Elsevier, (20080000), vol. 1
    - CSERNUS VJSZENDE BSCHALLY AV, "Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivo. A histological and immunohistochemical study", Int J Pept Protein Res, (19900000), vol. 35, no. 6, pages 557 - 65
    - MASUDA IMATSUO TYASUDA TMATSUO N, "Gene transfer with liposomes to the intraocular tissues by different routes of administration", Invest Ophthalmol Vis Sci, (19960000), vol. 37, no. 9, pages 1914 - 20
    - NORSEEN et al., Molecular and cellular biology, (20120000), vol. 32, pages 2010 - 9
    - GERALDES et al., "Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy", Nature medicine, (20090000), vol. 15, pages 1298 - 306
    - NAYAK et al., "A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes", The Journal of experimental medicine, (19880000), vol. 167, doi:10.1084/jem.167.3.1003, pages 1003 - 15, XP009083524

DOI:   http://dx.doi.org/10.1084/jem.167.3.1003
    - LIANG et al., Nature protocols, (20070000), vol. 2, pages 329 - 33
    - KISSLER et al., Methods in molecular biology, (20090000), vol. 555, pages 109 - 18
    - BOURNE et al., "Causes of vision loss worldwide, 1990-2010: a systematic analysis", The Lancet Global health, (20130000), vol. 1, pages e339 - 49
    - AIELLO et al., "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders", The New England journal of medicine, (19940000), vol. 331, doi:10.1056/NEJM199412013312203, pages 1480 - 7, XP002690192

DOI:   http://dx.doi.org/10.1056/NEJM199412013312203
    - AIELLO et al., "Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins", Proceedings of the National Academy of Sciences of the United States of America, (19950000), vol. 92, doi:10.1073/pnas.92.23.10457, pages 10457 - 61, XP002043159

DOI:   http://dx.doi.org/10.1073/pnas.92.23.10457
    - DIABETIC RETINOPATHY CLINICAL RESEARCH NELMAN MJAIELLO LP et al., "Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema", Ophthalmology, (20100000), vol. 117, pages 1064 - 77
    - KONDOKAHN, "Altered insulin signaling in retinal tissue in diabetic states", The Journal of biological chemistry, (20040000), vol. 279, pages 37997 - 8006
    - REITER et al., "Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin", Diabetes, (20060000), vol. 55, pages 1148 - 56
    - MIZUTANI et al., "Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy", The Journal of clinical investigation, (19960000), vol. 97, doi:10.1172/JCI118746, pages 2883 - 90, XP055001738

DOI:   http://dx.doi.org/10.1172/JCI118746
    - COGAN et al., "Retinal vascular patterns. IV. Diabetic retinopathy", Archives of ophthalmology, (19610000), vol. 66, pages 366 - 78
    - BARBER et al., "Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin", The Journal of clinical investigation, (19980000), vol. 102, pages 783 - 91
    - VAN DIJK et al., "Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy", Investigative ophthalmology & visual science, (20090000), vol. 50, pages 3404 - 9
    - BEARSE et al., "Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy", Investigative ophthalmology & visual science, (20040000), vol. 45, pages 3259 - 65
    - BRESNICKPALTA, "Predicting progression to severe proliferative diabetic retinopathy", Archives of ophthalmology, (19870000), vol. 105, pages 810 - 4
    - ANTONETTI et al., "Diabetic retinopathy", The New England journal of medicine, (20120000), vol. 366, doi:10.1056/NEJMra1005073, pages 1227 - 39, XP008181175

DOI:   http://dx.doi.org/10.1056/NEJMra1005073
    - GAO et al., "Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy", Journal of proteome research, (20080000), vol. 7, doi:10.1021/pr800112g, pages 2516 - 25, XP055028561

DOI:   http://dx.doi.org/10.1021/pr800112g
    - SUN et al., "Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study", Diabetes care, (20110000), vol. 34, pages 968 - 74
    - KEENAN et al., "Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study", Diabetes, (20100000), vol. 59, pages 2846 - 53
    - KERN et al., "Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop", Molecular vision, (20100000), vol. 16, pages 1629 - 39
    - CHADER, "Interphotoreceptor retinoid-binding protein (IRBP): a model protein for molecular biological and clinically relevant studies. Friedenwald lecture", Investigative ophthalmology & visual science, (19890000), vol. 30, pages 7 - 22
    - FONG et al., "Purification and characterization of a retinol-binding glycoprotein synthesized and secreted by bovine neural retina", The Journal of biological chemistry, (19840000), vol. 259, pages 6534 - 42
    - FONG et al., "Characterization, localization, and biosynthesis of an interstitial retinol-binding glycoprotein in the human eye", Journal of neurochemistry, (19840000), vol. 42, pages 1667 - 76
    - WIGGERT et al., "Immunochemical distribution of interphotoreceptor retinoid-binding protein in selected species", Investigative ophthalmology & visual science, (19860000), vol. 27, pages 1041 - 9
    - GARCIA-RAMIREZ et al., "Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy", Diabetologia, (20090000), vol. 52, pages 2633 - 41
    - DESJARDIN et al., "Transcription of photoreceptor genes during fetal retinal development. Evidence for positive and negative regulation", The Journal of biological chemistry, (19930000), vol. 268, pages 6953 - 60
    - HO et al., "Mechanism of vitamin A movement between rod outer segments, interphotoreceptor retinoid-binding protein, and liposomes", The Journal of biological chemistry, (19890000), vol. 264, pages 928 - 35
    - DEN HOLLANDER et al., "A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa", Investigative ophthalmology & visual science, (20090000), vol. 50, pages 1864 - 72
    - KSANTINI et al., "Screening genes of the visual cycle RGR, RBP1 and RBP3 identifies rare sequence variations", Ophthalmic genetics, (20100000), vol. 31, pages 200 - 4
    - BRIDGES et al., "Interstitial retinol-binding protein (IRBP) in subretinal fluid", Investigative ophthalmology & visual science, (19860000), vol. 27, pages 1027 - 30
    - NEWSOME et al., "Interphotoreceptor retinoid-binding protein levels in subretinal fluid from rhegmatogenous retinal detachment and retinopathy of prematurity", Archives of ophthalmology, (19880000), vol. 106, pages 106 - 10
    - WISARD et al., "Exaggerated eye growth in IRBP-deficient mice in early development", Investigative ophthalmology & visual science, (20110000), vol. 52, pages 5804 - 11
    - SATO et al., "Receptor interacting protein kinase-mediated necrosis contributes to cone and rod photoreceptor degeneration in the retina lacking interphotoreceptor retinoid-binding protein", The Journal of neuroscience : the official journal of the Society for Neuroscience, (20130000), vol. 33, pages 17458 - 68
    - RIPPS et al., "The rhodopsin cycle is preserved in IRBP ''knockout'' mice despite abnormalities in retinal structure and function", Visual neuroscience, (20000000), vol. 17, pages 97 - 105
    - GERALDES et al., "Selective regulation of heme oxygenase-1 expression and function by insulin through IRSl/phosphoinositide 3-kinase/Akt-2 pathway", The Journal of biological chemistry, (20080000), vol. 283, pages 34327 - 36
    - BAZAN et al., "Endogenous fatty acids are covalently and noncovalently bound to interphotoreceptor retinoid-binding protein in the monkey retina", The Journal of biological chemistry, (19850000), vol. 260, pages 13677 - 80
    - SUZUMA et al., "Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways", The Journal of biological chemistry, (20020000), vol. 277, pages 1047 - 57
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.